Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 8: 50th year of the DMDG
Research Articles
The in vitro metabolism and in vivo pharmacokinetics of the bacterial β-glucuronidase inhibitor UNC10201652
Anna Kerinsa Cyprotex Discovery, Macclesfield, UK
https://orcid.org/0000-0001-7851-7542
https://orcid.org/0000-0001-7851-7542, Marta Koszyczareka Cyprotex Discovery, Macclesfield, UKhttps://orcid.org/0000-0003-4322-3338
https://orcid.org/0000-0003-4322-3338, , Phil Butlera Cyprotex Discovery, Macclesfield, UKhttps://orcid.org/0000-0003-0449-4987
https://orcid.org/0000-0003-0449-4987, , , , Matthew R. Redinboc Departments of Chemistry, Biochemistry & Biophysics, and Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAhttps://orcid.org/0000-0003-0814-5346
https://orcid.org/0000-0003-0814-5346 & Ian D. Wilsond Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UKCorrespondence[email protected]
https://orcid.org/0000-0002-8558-7394
https://orcid.org/0000-0002-8558-7394 show all